Lung cancer continues to be one of the most prevalent and difficult cancers globally. The presentation "Lung Cancer Updates" presents the current findings in diagnosis, treatment, and investigation for both small cell and non-small cell lung cancers.".
Early diagnosis is important, and the session discusses new screening methods, such as low-dose CT scans and molecular tests, that detect lung cancer early in a stage where it can be treated. Imaging and biomarker advances are facilitating more targeted diagnosis and personalized treatment planning.
Treatment approaches covered are surgery, radiation, chemotherapy, targeted therapies, and immunotherapy. Targeted therapies target specific genetic aberrations, and the immunotherapies activate the patient's own immune system against tumor cells. Combination therapies are being used more to enhance results and treat resistance. Supportive care interventions to enhance quality of life for the patient during treatment are also discussed in the session.
Delegates will learn about the latest research, clinical trial evidence, and new therapies that are revolutionizing lung cancer management. This session highlights the value of early detection, individualized medicine, and multidisciplinary care in improving survival and outcomes for patients. Participants will have a complete overview of the latest trends and future possibilities in the management of lung cancer.
Welcome to the Cancer and Oncology Conference 2026, where global researchers, clinicians, and academics meet to share advances in cancer biology, precision medicine, diagnostics, therapies, and global solutions for patient care.
